NASDAQ
No price data available for this timeframe.
Gossamer Bio, Inc. (GOSS) has a price/sales ratio of 14.62x as of Friday, May 22, 2026. This represents a 3176.62% increase compared to its 12-month average of 0.45x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.